NCT04369508 PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy Status UNKNOWN Phase N/A
NCT04357717 ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting Status TERMINATED Phase N/A
NCT04356430 Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer Status UNKNOWN Phase PHASE2
NCT04354064 Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors Status RECRUITING Phase N/A
NCT04350788 Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program Status COMPLETED Phase NA
NCT04349501 Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) Status ACTIVE_NOT_RECRUITING Phase NA
NCT04348682 Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging Status APPROVED_FOR_MARKETING Phase N/A
NCT04346225 Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer Status RECRUITING Phase PHASE2
NCT04340245 Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04340024 Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients Status RECRUITING Phase N/A
NCT04337580 Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer Status RECRUITING Phase PHASE2
NCT04337099 A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer Status AVAILABLE Phase N/A
NCT04335682 Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide Status ACTIVE_NOT_RECRUITING Phase PHASE2